References
- Small DM. Cellular mechanisms for lipid deposition in atherosclerosis. N Engl J Med 1977: 297: 873–7
- Nicolosi RJ. Hajnacki JL. Llansa N, et al. Diet and llpoprotein influence on primate atherosclerosis (39863). Proc Soc Exp Biol Mrd 1977: 156(1): 1–7
- Nash DT. Dr Nash's natural diet book. New York: Grosset fit Dunlap. 1978
- Nash DT, Gensini G, Simon H. et al. The Erysichthon syndrome: progression of coronary atherosclerosis and hyperlipidemia Circulation 1977;56(3): 363–5
- Kuo PT, Hayase K. Kostis JB. et al. Use of combined diet and colestipol in long-term (7–71b years) treatment of patients with type II hyperilpoproteinemia. Circulation 1979: 59(2): 199–211
- Barndt R Jr. Blankenhorn DH, Crawford DW. et al. Regression and progression of early femoral atherosclerosis in treated hyprelipoproteinemic patients. Ann Intern Med 1977: 86: 139–46
- Nash DT. Gensini G. Esente P. Lipid lowering therapy and the progression of coronary artery disease Circulation 1980;62(Suppl III): 122
- Nash DT. Probucol. a new cholesterol lowering drug. J Med 1975: 6: 305–15
- Nash DT. Safety and efficacy of probucol during one year of administration. J Clin Pharmacol 1974: 14: 470–5
- Davignon J, LeLorier J. Experience with probucol in the treatment of hypercholesterolemia. Presented before the VII International Symposium on Drugs Affecting Lipid Metabolism. Milan. Italy. 1980
- Harris RS. Long term oral administration of 4.4′ (lsopropylidenedtthio) bis(2.6 dl-t-butylphenol)in the management of hypercholesierolemia. J Am Geriatr Soc 1974: 22: 167–70
- Heel RC. Brogden RN. Speight TM. et al. Probucol: a review of its pharmacological properties and therapeutic use in patients with hypereholesterolemia. Drugs 1978: 15: 409–28
- Wissler RW. Vesselinovitch D. The effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkeys. Presented before Symposium on Lipoproteins and Athcrosdcrosis. Lugano. Switzerland. 1981: 1–3
- McCaughan D. The long term effects of probucol on serum lipid levels. Arch Intern Med 1981: 141: 1428–32
- Nash DT. Gemfibrozil—a new lipid lowering agent J Med 1980: 11: 107–16